Literature DB >> 32251918

Trends in the incidence and DALYs of bipolar disorder at global, regional, and national levels: Results from the global burden of Disease Study 2017.

Hairong He1, Chuanyu Hu2, Zhenhu Ren3, Ling Bai4, Fan Gao4, Jun Lyu5.   

Abstract

The objective of this study is to assess the global, regional, and national burden of bipolar disorder (BPD) from 1990 to 2017, by gender, age, and social-demographic index (SDI) from the 2017 Global Burden of Disease (GBD) study. We collected detailed information from GBD on the numbers of incidence cases and disability-adjusted life years (DALYs), age-standardized incidence rate (ASIR), and age-standardized DALYs rate (ASDR) during 1990-2017. Estimated annual percentage changes (EAPCs) were calculated to assess ASIR and ASDR trends. GBD data estimated that BPD incidences increased by 47.74%, from 3.06 million in 1990 to 4.53 million in 2017, and the DALYs increased by 54.4%, from 6.02 million in 1990 to 9.29 million in 2017. Over the 28-year period between 1990 and 2017, the ASIR and ASDR increased only slightly (EAPC = 0.14 and 0.05 for ASIR and ASDR, respectively). Subjects aged 10-19 years contributed the most to the total number of incidence cases, while those aged 20-44 years contributed the most to the number of DALYs. The ASIR and ASDR were highest in tropical Latin America and lowest in East Asia. Areas in the lowest sociodemographic index (SDI) quintile showed the highest ASIR (about 64/100,000), and those in the highest SDI quintile showed the highest ASDR (about 140/100,000). In conclusion, while the ASIR and ASDR due to BPD have been stable, the absolute incidence and DALYs remain high, which represents an increasing burden on health-care systems.
Copyright © 2020 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Bipolar disorder; DALYs; GBD2017; Incidence

Mesh:

Year:  2020        PMID: 32251918     DOI: 10.1016/j.jpsychires.2020.03.015

Source DB:  PubMed          Journal:  J Psychiatr Res        ISSN: 0022-3956            Impact factor:   4.791


  4 in total

Review 1.  Existing and emerging pharmacological approaches to the treatment of mania: A critical overview.

Authors:  Giulio Sparacino; Norma Verdolini; Eduard Vieta; Isabella Pacchiarotti
Journal:  Transl Psychiatry       Date:  2022-04-23       Impact factor: 7.989

2.  Associations between childhood maltreatment and oxidative nucleoside damage in affective disorders.

Authors:  Johanne Kofod Damm Eriksen; Klara Coello; Sharleny Stanislaus; Hanne Lie Kjærstad; Kimie Stefanie Ormstrup Sletved; Roger S McIntyre; Maria Faurholt-Jepsen; Kamilla K Miskowiak; Henrik Enghusen Poulsen; Lars Vedel Kessing; Maj Vinberg
Journal:  Eur Psychiatry       Date:  2022-08-11       Impact factor: 7.156

3.  Prevalence and associated factors of obesity and overweight in Chinese patients with bipolar disorder.

Authors:  Wenying Yi; Haibo Wu; Ruikeng Li; Haijing Li; Zhen Song; Shenglin She; Yingjun Zheng
Journal:  Front Psychiatry       Date:  2022-09-06       Impact factor: 5.435

4.  Genetic Polymorphisms in miR-137 and Its Target Genes, TCF4 and CACNA1C, Contribute to the Risk of Bipolar Disorder: A Preliminary Case-Control Study and Bioinformatics Analysis.

Authors:  Mohammad Ali Mokhtari; Saman Sargazi; Ramin Saravani; Milad Heidari Nia; Shekoufeh Mirinejad; Kinga Hadzsiev; Judit Bene; Mansoor Shakiba
Journal:  Dis Markers       Date:  2022-09-22       Impact factor: 3.464

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.